financetom
Business
financetom
/
Business
/
Consumer healthcare group Haleon raises medium-term profit forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Consumer healthcare group Haleon raises medium-term profit forecast
May 25, 2025 11:10 PM

May 1 (Reuters) - Haleon ( HLN ) on Thursday raised its

medium-term target for profit growth from 2026, banking on

strength in key markets and costs cuts within its supply chain,

which would save the consumer healthcare group 800 million

pounds ($1.07 billion) in the next five years.

($1 = 0.7498 pounds)

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Mrigank

Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Polaris' Improved Volume Flow-Through to Offset Tariff Pressures, Morgan Stanley Says
Polaris' Improved Volume Flow-Through to Offset Tariff Pressures, Morgan Stanley Says
Oct 31, 2025
10:38 AM EDT, 10/31/2025 (MT Newswires) -- Polaris' (PII) improved volume flow-through from retail and accretion from the Indian Motorcycle deal are expected to offset tariff cost headwinds, which are forecast to increase sequentially in Q4, Morgan Stanley said in a Friday report. The brokerage said it raised its 2026 EPS forecast to $2.15 from $2.10. It also said it...
Form 8.3 - Unite Group plc
Form 8.3 - Unite Group plc
Oct 31, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Bristol-Myers Squibb's Lack of Update on Phase 3 Alzheimer's Trial 'Surprising,' Morgan Stanley Says
Bristol-Myers Squibb's Lack of Update on Phase 3 Alzheimer's Trial 'Surprising,' Morgan Stanley Says
Oct 31, 2025
10:37 AM EDT, 10/31/2025 (MT Newswires) -- Bristol-Myers Squibb's ( BMY ) lack of update on its ADEPT-2 phase-3 Alzheimer's psychosis trial or the ongoing review of other late-stage trials on its Q3 earnings call was surprising, Morgan Stanley analysts said in a Friday note. Bristol-Myers topped estimates for its Q3 financial results, but risks remain to the company's 2026...
iA Financial Completes Acquisition of RF Capital
iA Financial Completes Acquisition of RF Capital
Oct 31, 2025
10:44 AM EDT, 10/31/2025 (MT Newswires) -- iA Financial Corporation ( IAFNF ) said Friday it has completed the acquisition of wealth management company, RF Capital Group. RF Capital has more than $43.6 billion in assets under administration. This, combined with iA Financial's ( IAFNF ) total assets under management and administration, raises the total to over $330 billion as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved